Stocktoria
Citius Pharmaceuticals, Inc. CTXR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-08-03
Citius Pharmaceuticals, Inc. statistics & valuation
Market cap$14.8M
P / B0.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -37017.8% | -26146.5% |
| Net margin | — | — | — | -37378.5% | -25616.0% |
| FCF margin | — | — | — | — | -26952.6% |
| Return on assets | — | — | -31.4% | -29.5% | -16.2% |
| Return on equity | — | — | -35.6% | -32.5% | -17.4% |
| Current ratio | 0.62 | 0.40 | 5.95 | 9.84 | 18.28 |
| Revenue growth | — | — | — | 0.0% | 0.0% |
Source: SEC EDGAR filings · CIK 0001506251 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.